Inventor
PONS JAUME
US59 patents
⚠️ This page may combine multiple inventors who share the name “PONS JAUME”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ALX ONCOLOGY INC
11 patentsUS10259859B2Apr 16, 2019
Constructs having a SIRP-α domain or variant thereof
ALX ONCOLOGY INC35 citations95
US10696730B2Jun 30, 2020
Constructs having a SIRP-alpha domain or variant thereof
ALX ONCOLOGY INC11 citations93
US11401338B2Aug 2, 2022
Antibodies against signal-regulatory protein alpha and methods of use
ALX ONCOLOGY INC6 citations84
US11208459B2Dec 28, 2021
Constructs having a SIRP-alpha domain or variant thereof
ALX ONCOLOGY INC8 citations83
US11292850B2Apr 5, 2022
Antibodies against signal-regulatory protein α and methods of use
ALX ONCOLOGY INC2 citations72
US12098214B2Sep 24, 2024
Combination therapies for treating cancer
ALX ONCOLOGY INC2 citations71
US11639376B2May 2, 2023
Constructs having a SIRP-α domain or variant thereof
ALX ONCOLOGY INC3 citations71
US11242404B2Feb 8, 2022
Antibodies against signal-regulatory protein alpha and methods of use
ALX ONCOLOGY INC3 citations71
US11613564B2Mar 28, 2023
Methods of treating cancer
ALX ONCOLOGY INC3 citations70
US11939393B2Mar 26, 2024
Antibodies against signal-regulatory protein alpha and methods of use
ALX ONCOLOGY INC1 citations62
US12404340B2Sep 2, 2025
Antibodies against signal-regulatory protein alpha and methods of use
ALX ONCOLOGY INC0 citations61
RINAT NEUROSCIENCE CORP
10 patentsUS8007794B2Aug 30, 2011
Antagonist antibodies directed against calcitonin gene-related peptide and methods using same
RINAT NEUROSCIENCE CORP51 citations97
US10138303B2Nov 27, 2018
Heterodimeric proteins and methods for producing and purifying them
RINAT NEUROSCIENCE CORP14 citations92
US7763250B2Jul 27, 2010
Antibodies directed against amyloid-beta peptide and nucleic acids encoding same
RINAT NEUROSCIENCE CORP23 citations92
US7927594B2Apr 19, 2011
Antibodies directed against amyloid-beta peptide
RINAT NEUROSCIENCE CORP24 citations91
US9175093B2Nov 3, 2015
PCSK9 antagonists
RINAT NEUROSCIENCE CORP6 citations83
US9708398B2Jul 18, 2017
Anti-NGF antibodies and methods using same
RINAT NEUROSCIENCE CORP2 citations73
US7807165B2Oct 5, 2010
Antibodies directed against amyloid-beta peptide and methods using same
RINAT NEUROSCIENCE CORP5 citations72
US11008386B2May 18, 2021
Anti-NGF antibodies and methods using same
RINAT NEUROSCIENCE CORP0 citations63
US7968690B2Jun 28, 2011
Agonist anti-trkC antibodies and methods using same
RINAT NEUROSCIENCE CORP3 citations63
US11390689B2Jul 19, 2022
Heterodimeric proteins and methods for producing and purifying them
RINAT NEUROSCIENCE CORP1 citations62
LABRYS BIOLOG INC
8 patentsUS8734802B1May 27, 2014
Methods of treating vasomotor symptoms using antibodies
LABRYS BIOLOG INC54 citations98
US8597649B2Dec 3, 2013
Antagonist antibodies directed against calcitonin gene-related peptide and methods using same
LABRYS BIOLOG INC51 citations98
US9266951B2Feb 23, 2016
Antagonist antibodies directed against calcitonin gene-related peptide and methods using same
LABRYS BIOLOG INC23 citations96
US9115194B2Aug 25, 2015
Antagonist antibodies directed against calcitonin gene-related peptide and methods using same
LABRYS BIOLOG INC26 citations96
US9365648B1Jun 14, 2016
Methods of using anti-CGRP antagonist antibodies
LABRYS BIOLOG INC16 citations92
US9346881B2May 24, 2016
Antagonist antibodies directed against calcitonin gene-related peptide and methods using same
LABRYS BIOLOG INC16 citations92
US9340614B2May 17, 2016
Antagonist antibodies directed against calcitonin gene-related peptide and methods using same
LABRYS BIOLOG INC16 citations92
US9328168B2May 3, 2016
Methods of using anti-CGRP antagonist antibodies
LABRYS BIOLOG INC16 citations92
TEVA PHARMACEUTICALS INT GMBH
5 patentsUS9890210B2Feb 13, 2018
Antagonist antibodies directed against calcitonin gene-related peptide
TEVA PHARMACEUTICALS INT GMBH11 citations92
US9890211B2Feb 13, 2018
Antagonist antibodies directed against calcitonin gene-related peptide
TEVA PHARMACEUTICALS INT GMBH11 citations92
US9884907B2Feb 6, 2018
Methods for treating headache using antagonist antibodies directed against calcitonin gene-related peptide
TEVA PHARMACEUTICALS INT GMBH15 citations92
US9884908B2Feb 6, 2018
Methods for treating headache using antagonist antibodies directed against calcitonin gene-related peptide
TEVA PHARMACEUTICALS INT GMBH15 citations92
US10329343B2Jun 25, 2019
Methods for treating headache using antagonist antibodies directed against calcitonin gene-related peptide
TEVA PHARMACEUTICALS INT GMBH5 citations84
PFIZER
3 patentsLIANG HONG
3 patentsUS8080243B2Dec 20, 2011
Isolated antibody which specifically binds to PCSK9
LIANG HONG139 citations97
US8426363B2Apr 23, 2013
Method for reducing a level of LDL-cholesterol by an antibody that specifically binds to PCSK9
LIANG HONG58 citations96
US8399646B2Mar 19, 2013
Isolated nucleic acid encoding an antibody which specifically binds to PCSK9 and a host cell that produces the antibody
LIANG HONG57 citations96
PONS JAUME
3 patentsROSENTHAL ARNON
3 patentsUS8398978B2Mar 19, 2013
Antibodies directed against amyloid-beta peptide and methods using same
ROSENTHAL ARNON2 citations62
US8425905B2Apr 23, 2013
Antibodies directed against amyloid-beta peptide and methods using same
ROSENTHAL ARNON3 citations61
US8268593B2Sep 18, 2012
Polynucleotides encoding antibodies directed against amyloid-beta peptide
ROSENTHAL ARNON3 citations61
ZELLER JOERG
1 patentHO WEI-HSIEN
1 patentSTROP PAVEL
1 patentPARALKAR VISHWAS MADHAV
1 patentShowing the top 50 of 59 patents by PatentIndex Score.